Obviousness-Type Double Patenting, PTA, and PTEs: Defeating ODP Rejections, Avoiding Terminal Disclaimers, Impact of In re Cellect
On October 16, 2023, Marbury Senior Partner Tom Irving and Partner Michelle O'Brien will be presenting a webinar on Obviousness-Type Double Patenting and discussing the Federal Circuit's In re Cellect decision. In Cellect, the CAFC found that ODP was to be evaluated after PTA is added on to patent term, potentially impacting whether a patent [...]